SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of January 2011
FRESENIUS MEDICAL CARE AG & Co. KGaA
(Translation of registrant’s name into English)
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82
On January 14, 2011 Fresenius Medical Care North America issued an Investor News announcing a voluntary recall of specific lots of CombiSet True Flow Series™Hemodialysis Blood Tubing Set with priming Set and Transducer Protectors for use with the Blood Volume Monitor.
EXHIBITS
Exhibit 99.1 | Investor News Release issued January 14, 2011. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DATE: January 18, 2011
| Fresenius Medical Care AG & Co. KGaA, a partnership limited by shares, represented by: |
| | |
| fresenius medical care management ag, its general partner |
| | |
| By: | /s/ Dr. Ben J. Lipps |
| | Name: | Dr. Ben J. Lipps |
| | Title: | Chief Executive Officer and Chairman of the Management Board of the General Partner |
| | |
| By: | /s/ Michael Brosnan |
| | Name: | Michael Brosnan |
| | Title: | Chief Financial Officer and Member of the Management Board of the General Partner |